<91E F193FA967B97D58FB B2D8FB4985E8F572E696E6464>

Size: px
Start display at page:

Download "<91E F193FA967B97D58FB B2D8FB4985E8F572E696E6464>"

Transcription

1

2 EL EL EL EL EL EL

3 EL EL EL-9 9 D EL EL EL-12 12

4 EL Vol.34-4 Late preterm infants LPI Vol S1 1 S S1-2 S1-3 Body compositional disorderbcd S

5 S2 2 ABC S2-1 S2-2 S2-3 S S3 3 S3-1 S3-2 S3-3 3 EPADHA S3-4

6 S4 4 S4-1 S4-2 S S5 5 S5-1 S5-2 S5-3 S5-4

7 S6 6 S6-1 Modified ERAS S6-2 S6-3 S DS NTT PD PD-1 Wilson

8 PD-2 1 Wilson PD-3 2 Wilson WS 3 WS-1 WS-2 WS FM2014 Up to Date FM-1 FM-2 FM-3

9 FM-4 NR NR SS University of Minnesota Evidence-based NutritionResearch on Walnuts and Health SS-1 Dietary Patterns, Food, and NutrientsEvidence-based Research Findings University of Minnesota SS-2 Walnuts Elicit Many Cardiovascular Benefits The Pennsylvania State University SS-3 The PREDIMED StudyChanging the Landscape of Cardiovascular Risk Reduction University of Barcelona SS-4 Evidence in Support of Dietary Recommendations for Cancer Prevention University of Connecticut LS LS2 2

10 LS3 3 NST LS LS LS LS7 7 EPA LS8 8 Mg

11 Y Y-02 Formula Y-03 Y Y-05 QOL 12 Y-06 Y g

12 Y Y-09 Y-10 12

13 O O O O-004 VPP O O-006 LDL 12 3

14 O-007 LDL LDL 12 O O O O O O

15 O O O O-017 4,5 EPA O-018 O

16 O , O O O AI LH O-024 O O

17 O O O-029 KAIDEC Study O O-031 PES 1MIWA CLINIC 2 O O-033 1

18 O O O O NST O-038 EPA 1 1NST O O

19 O O-042 MNA-SF MNA 123 O-043 NR O-044 O-045 O O

20 O O O O O-052 CoQ10- CD C CoQ10 12 O-053 R O-054

21 O O O-057 O-058 O-059 MS O-060 CKD O O

22 O-063 O O O-066 O-067 O-068 go/no-go 123 O

23 O-070 O-071 O Acetoxychavicol acetate O-073 O O O-076 apoa-v 12 O

24 O O O O O O O O-085 NST 1 2

25 O O-087 O-088 TM O-089 ApoB-48 Caco-2 O-090 REF-P1 O O O-093

26 O O O O-097 Bioelectrical Phase Angle O O-099 D 1 23 O O

27 O O O O O O-107 O-108 hepcidin 1

28 O O O O O O O-115 3

29 O-116 O O-118 REF-P O-119 PEG 12 O O O O-123

30 O-124 Q O O D O O-128 CDK G45 12 O-129 O-130 IgA CRF 12 O

1 ご挨拶・講演等.indd

1 ご挨拶・講演等.indd 8 28 D 1313 9 00 9 40-1 O-001 O-002 O-003 LDL O-004 LDL LDL O-005 8 28 D 1313 9 40 10 20-2 O-006 O-007 O-008 B 1 O-009 O-010 - 8 28 D 1313 10 20 10 52-1 O-011 O-012 5 O-013 3 O-014 CKD 24 8 28 D 1313 10

More information

立命館

立命館 SPORT AND HEALTH SCIENCE Research Study Report 2011 01 02 03 Sport and Health Science 04 PICK UP VOICE 05 Sport and Health Science 06 PICK UP VOICE 07 Sport and Health Science PICK UP VOICE 08 09 Sport

More information

2

2 5 15.8% 17.1% 13.7% 15 1 34.0%3 1 3 25.7 4 1 76.5 3.3 2 23 3225 36 72.0 13.3 1 26 38 ( 77.8 87.8 69.5 2010 3 20 60 7 20 2 3 1 2 ( 77.8 87.8 69.5 2010 87.9 66.5 3 20 83.030 92.240 93.6 50 91.660 6065 72.9

More information

F 3 12:0013:00 LS

F 3 12:0013:00 LS 3 6 2 1 4F 8:159:15 MS3-1 Dupilumab MS3-2 IL!4/13 Biologic therapydupilumabfor atopic dermatitis 12:0013:00 LS13-1 /B LS13-2 3 6 2 2 4F 3 12:0013:00 LS14 2018 3 6 2 3 4F 2 8:159:15 MS4-1 MS4-2 9:3511:35

More information

社葬事前手続き

社葬事前手続き 2 ... 4... 4... 5 1... 5 2... 5 3... 5 4... 5 5... 5 6... 5 7... 5 8... 6 9... 6 10... 6... 6 1... 6 2... 6 3... 7 4... 7... 8 1 2.... 8 2 2.... 9 3 4.. 3 4. 1 2 3 4 5 6 7 5 8 9 10 I 1 6 2 EL 3 4 24 7

More information

untitled

untitled 10 23 11 1 1 (3) 40 0 2,861 2,697 571 6.041 75,628 6,062 229 442 2 3 4 5 6 7 8 9 10 11 12 JIS B 856230 13 14 15 16 17 18 19 20 21 22 23 24 1 25 NTT au NTT i NTT au NTT 26 27 161 (17,102 )10 23 25 (FM)

More information

Netcommunity SYSTEM X7000 IPコードレス電話機 取扱説明書

Netcommunity SYSTEM X7000 IPコードレス電話機 取扱説明書 4 5 6 7 8 9 . 4 DS 0 4 5 4 4 4 5 5 6 7 8 9 0 4 5 6 7 8 9 4 5 6 4 0 4 4 4 4 5 6 7 8 9 40 4 4 4 4 44 45 4 6 7 5 46 47 4 5 6 48 49 50 5 4 5 4 5 6 5 5 6 4 54 4 5 6 7 55 5 6 4 56 4 5 6 57 4 5 6 7 58 4

More information

.A. D.S

.A. D.S 1999-1- .A. D.S 1996 2001 1999-2- -3- 1 p.16 17 18 19 2-4- 1-5- 1~2 1~2 2 5 1 34 2 10 3 2.6 2.85 3.05 2.9 2.9 3.16 4 7 9 9 17 9 25 10 3 10 8 10 17 10 18 10 22 11 29-6- 1 p.1-7- p.5-8- p.9 10 12 13-9- 2

More information

1 2 3 4 5 6 X Y ABC A ABC B 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 13 18 30 P331 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ( ) 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59

More information

26 2 3 4 5 8 9 6 7 2 3 4 5 2 6 7 3 8 9 3 0 4 2 4 3 4 4 5 6 5 7 6 2 2 A B C ABC 8 9 6 3 3 4 4 20 2 6 2 2 3 3 4 4 5 5 22 6 6 7 7 23 6 2 2 3 3 4 4 24 2 2 3 3 4 4 25 6 2 2 3 3 4 4 26 2 2 3 3 27 6 4 4 5 5

More information

mogiJugyo_slide_full.dvi

mogiJugyo_slide_full.dvi a 2 + b 2 = c 2 (a, b, c) a 2 a 2 = a a a 1/ 78 2/ 78 3/ 78 4/ 78 180 5/ 78 http://www.kaijo.ed.jp/ 6/ 78 a, b, c ABC C a b B c A C 90 a 2 + b 2 = c 2 7/ 78 C a b a 2 +b 2 = c 2 B c A a 2 a a 2 = a a 8/

More information

untitled

untitled 70.0 60.0 50.0 40.0 30.0 20.0 10.0 0.0 18.5 18 60.4 6.3 45.5 18.9 41.8 5.0 29.3 17.1 1.2 3.7 0.0 0.0 1.5 19 20 21 22 2.50 2.00 1.50 1.00 0.50 0.00 19 2.38 1.48 1.02 2.05 0.11 0.00 0.00 20 21 1.22 0.44

More information

Microsoft Word - 表紙資料2-4

Microsoft Word - 表紙資料2-4 (1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)

More information

1991 1991 FAX e-mail 1999.12. 1 1999.12. 31 042-783-2305 4342 194-0298 F 042-783-2311 79 98.11 A4.39 97.11 21 A5.90 97. A5.286 98. 21 A5.197 99.10 A5.276 99.10 B5.22 99.10 B5.24 99. B40.170 99. A5.174

More information

™…{,

™…{, 16:30-17:40 1-36 1-37 1-38 1-39 1-40 1-41 1-42 33 10:00-11:10 1-43 1-44 1-45 1-46 1-47 1-48 1-49 12:00-12:50 LS4 34 16:30-17:40 1-50 1-51 1-52 1-53 1-54 1-55 1-56 35 16:30-17:40 1-57 1-58 1-59 1-60 1-61

More information

みさき_1

みさき_1 2 3 4 5 6 7 1F 2F 8 9 10 11 17 18 19 20 21 22 23 24 31 25 26 27 28 29 30 8 1 2 3 4 5 6 7 6 8 7 16 7 8 9 10 11 12 14 15 13 17 23 Vol.41 8 6 20 11 7 15 7 23 7 7 7 16 23 23 8 13 18:00 22:00 722

More information

Vol..3 2010 2 10 2

Vol..3 2010 2 10 2 1 Vol..3 2010 2 10 2 Vol..3 2010 2 10 3 Vol..3 2010 2 10 4 Vol..3 2010 2 10 5 Vol..3 2010 2 10 6 Vol..3 2010 2 10 7 Vol..3 2010 2 10 8 Vol..3 2010 2 10 9 Vol..3 2010 2 10 10 Vol..3 2010 2 10 11 Vol..3

More information

H21_report

H21_report vol.4 1 2 6 10 14 18 20 22 24 25 1 2 2172 73 3 21925 926 21125 126 4 5 6 21629 630 7 21107 108 21127 128 8 9 10 21616 617 11 211026 1027 211213 1214 12 13 14 21713 714 15 2194 95 211031 111 16 17 18 19

More information

2009-9-2.indd

2009-9-2.indd Q No.1441 Q No.1442 Vol.33 NO.9 (2009) 30 (614) Q No.1443 Vol.33 NO.9 (2009) 31 (615) Q No.1444 Vol.33 NO.9 (2009) 32 (616) Vol.33 NO.9 (2009) 33 (617) Vol.33 NO.9 (2009) 34 (618) Q No.1445 Vol.33 NO.9

More information

untitled

untitled Vol.27 1 Vol.27 2 Vol.27 3 Vol.27 4 Vol.27 5 Vol.27 6 Vol.27 7 Vol.27 8 Vol.27 9 Vol.27 10 11 Vol.27 Vol.27 12 Vol.27 13 Vol.27 14 Vol.27 15 Vol.27 16 Vol.27 17 Vol.27 2007 10 29 18 http://www.nira.or.jp/index.html

More information

Vol.14 98 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 62 63 64 65 66 67 68

More information

untitled

untitled 12 3 10 27 1 100 1/10 1/3 2012 24 27 22 23 153 8407 26 28 563 275 26 260 275 120 67 21 15 98 70 8407 7791 616 70.2 19 50 100 300 vol.195 12 10 12 22 11 23 30 0.022 22 11 23 1 9230+0.022 22 11 23 vol.194

More information